Clinical trial
Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease
NCT03136679 is registered in ClinicalTrials.gov with Baylor Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Discovery of Novel Biomarkers That Will Lead to the Early Detection of Alzheimer's Disease
- Lead sponsor
- Baylor Research Institute
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 22, 2011
- Completion date
- November 24, 2021
- Enrollment
- 95 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer disease, mild cognitive impairment